No matter how cynical the overall market is, Novavax, Inc. (NVAX) performance over the last week is recorded -9.09%

November 20, 2023, Novavax, Inc. (NASDAQ: NVAX) trading session started at the price of $5.75, that was -0.52% drop from the session before. During the day, the shares moved up to $5.75 and dropped to $5.5628 before settling in for the closing price of $5.73. A 52-week range for NVAX has been $5.61 – $21.34.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


During the last 5-year period, the sales growth of Healthcare Sector giant was 525.36%. When this article was written, the company’s average yearly earnings per share was at 56.61%. With a float of $110.21 million, this company’s outstanding shares have now reached $118.79 million.

Let’s determine the extent of company efficiency that accounts for 1992 employees. In terms of profitability, gross margin is +54.46, operating margin of -32.53, and the pretax margin is -32.98.

Novavax, Inc. (NVAX) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Novavax, Inc. stocks. The insider ownership of Novavax, Inc. is 7.23%, while institutional ownership is 52.96%. The most recent insider transaction that took place on Mar 10, was worth 6,500. In this transaction President, R&D of this company bought 1,000 shares at a rate of $6.50, taking the stock ownership to the 14,473 shares. Before that another transaction happened on Mar 07, when Company’s President, R&D bought 2,000 for $7.04, making the entire transaction worth $14,088. This insider now owns 13,473 shares in total.

Novavax, Inc. (NVAX) Recent Fiscal highlights

Going through the last 3-months fiscal report unveiled on the 9/29/2023, it has been observed that the corporation posted -$1.26 earnings per share (EPS) during the time that was better than consensus figure (set at -$1.83) by $0.57. This company achieved a net margin of -33.20. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 56.61% per share during the next fiscal year.

Novavax, Inc. (NASDAQ: NVAX) Trading Performance Indicators

You can see what Novavax, Inc. (NVAX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.65.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.38, a number that is poised to hit 0.16 in the next quarter and is forecasted to reach -0.80 in one year’s time.

Technical Analysis of Novavax, Inc. (NVAX)

Looking closely at Novavax, Inc. (NASDAQ: NVAX), its last 5-days average volume was 6.14 million, which is a drop from its year-to-date volume of 7.3 million. As of the previous 9 days, the stock’s Stochastic %D was 5.17%. Additionally, its Average True Range was 0.43.

During the past 100 days, Novavax, Inc.’s (NVAX) raw stochastic average was set at 2.90%, which indicates a significant decrease from 7.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.84% in the past 14 days, which was lower than the 84.85% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $6.88, while its 200-day Moving Average is $7.69. However, in the short run, Novavax, Inc.’s stock first resistance to watch stands at $5.78. Second resistance stands at $5.86. The third major resistance level sits at $5.97. If the price goes on to break the first support level at $5.59, it is likely to go to the next support level at $5.48. Now, if the price goes above the second support level, the third support stands at $5.40.

Novavax, Inc. (NASDAQ: NVAX) Key Stats

There are 118,790K outstanding shares of the company, which has a market capitalization of 677.10 million. As of now, sales total 1,982 M while income totals -657,940 K. Its latest quarter income was 186,990 K while its last quarter net income were -130,780 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Purple Innovation Inc (PRPL) is set for another landmark as it hit the volume of 1.33 million

Purple Innovation Inc (NASDAQ: PRPL) open the trading on November 30, 2023, with great promise as it jumped 0.68% to $0.62. During the day,...

uniQure N.V. (QURE) last month performance of 18.95% certainly makes it a sizzling prospect

Witnessing the stock’s movement on the chart, on November 30, 2023, uniQure N.V. (NASDAQ: QURE) had a quiet start as it plunged -0.29% to...

The key reasons why CRH Plc (CRH) is -0.25% away from 52-week high?

CRH Plc (NYSE: CRH) established initial surge of 0.37% at $62.75, as the Stock market unbolted on November 30, 2023. During the day, the...


Please enter your comment!
Please enter your name here